Utilization of drug for that remedy of bronchial asthma as monotherapy without a concomitant ICS is contraindicated; use only as added therapy for patients with asthma who're presently getting but are inadequately controlled on an ICS; never use drug for patients whose asthma is adequately managed on low-or medium-dose ICS https://sr900910987.newsbloger.com/28897267/the-2-minute-rule-for-pifithrin-α-hydrobromide